Delivery Order SPE2DB20D2014-SPE2DB24FC53C
Award Date
7/19/24
Potential Completion Date
7/22/24
Potential Value
$7.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a medical product, with a ceiling value of $8,568.40 and a period of performance through March 13, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,018.89 and is a delivery order under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical...
This $16,946.83 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the DLA with 4565255252 units of BUDESONIDE-FORMOTEROL 80-4.5 10.2GM medical products. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,310.40. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 8, 2025. This contract award is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide BUDESONIDE-FORMOTEROL 80-4.5 10.2GM medication. The contract has a ceiling value of $1,967.86 and a completion date of July 1, 2025. It is a firm fixed-price contract without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,749.70, is for the supply of BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of July 25, 2024 and is a firm fixed-price delivery order. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM. The contract is a firm fixed-price delivery order with a ceiling value of $7,664.33 and a performance period through June 18, 2025. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,671.50 and a period of performance through April 2, 2025. The contract is a Delivery Order and is priced on a Firm Fixed Price basis. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $1,421.64 and covers the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, which are pharmaceutical products used for medical treatment. The contract has no set-aside designation, indicating it was open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,278.81 firm fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a respiratory medication. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...